Software - Application
Compare Stocks
5 / 10Stock Comparison
SPT vs BRZE vs HUBS vs MANH vs ORCL
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Software - Application
Software - Infrastructure
SPT vs BRZE vs HUBS vs MANH vs ORCL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Software - Application | Software - Application | Software - Infrastructure |
| Market Cap | $409M | $2.31B | $12.58B | $8.50B | $559.27B |
| Revenue (TTM) | $458M | $738M | $3.30B | $1.10B | $64.08B |
| Net Income (TTM) | $-43M | $-131M | $100M | $217M | $16.21B |
| Gross Margin | 77.6% | 67.1% | 83.7% | 55.6% | 66.4% |
| Operating Margin | -9.5% | -19.6% | 1.9% | 25.6% | 30.8% |
| Forward P/E | 7.4x | 35.7x | 19.6x | 26.8x | 26.0x |
| Total Debt | $67M | $83M | $485M | $112M | $104.10B |
| Cash & Equiv. | $95M | $124M | $882M | $329M | $10.79B |
SPT vs BRZE vs HUBS vs MANH vs ORCL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| Sprout Social, Inc. (SPT) | 100 | 6.1 | -93.9% |
| Braze, Inc. (BRZE) | 100 | 29.7 | -70.3% |
| HubSpot, Inc. (HUBS) | 100 | 30.3 | -69.7% |
| Manhattan Associate… (MANH) | 100 | 91.9 | -8.1% |
| Oracle Corporation (ORCL) | 100 | 214.4 | +114.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SPT vs BRZE vs HUBS vs MANH vs ORCL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SPT ranks third and is worth considering specifically for value.
- Lower P/E (7.4x vs 26.0x)
BRZE is the clearest fit if your priority is growth.
- 24.4% revenue growth vs MANH's 3.7%
HUBS is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 19.2%, EPS growth 8.6%, 3Y rev CAGR 21.8%
- Lower volatility, beta 1.18, Low D/E 23.5%, current ratio 1.52x
- Beta 1.18, current ratio 1.52x
MANH is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 2 yrs, beta 1.10
- PEG 1.25 vs ORCL's 3.66
- Beta 1.10 vs ORCL's 1.59, lower leverage
- 28.0% ROA vs BRZE's -12.9%, ROIC 236.8% vs -20.5%
ORCL carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 425.1% 10Y total return vs HUBS's 469.1%
- 25.3% margin vs BRZE's -17.8%
- 0.9% yield; 18-year raise streak; the other 4 pay no meaningful dividend
- +31.6% vs SPT's -67.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 24.4% revenue growth vs MANH's 3.7% | |
| Value | Lower P/E (7.4x vs 26.0x) | |
| Quality / Margins | 25.3% margin vs BRZE's -17.8% | |
| Stability / Safety | Beta 1.10 vs ORCL's 1.59, lower leverage | |
| Dividends | 0.9% yield; 18-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +31.6% vs SPT's -67.1% | |
| Efficiency (ROA) | 28.0% ROA vs BRZE's -12.9%, ROIC 236.8% vs -20.5% |
SPT vs BRZE vs HUBS vs MANH vs ORCL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SPT vs BRZE vs HUBS vs MANH vs ORCL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ORCL leads in 2 of 6 categories
SPT leads 1 • MANH leads 1 • BRZE leads 0 • HUBS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — HUBS and ORCL each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ORCL is the larger business by revenue, generating $64.1B annually — 140.0x SPT's $458M. ORCL is the more profitable business, keeping 25.3% of every revenue dollar as net income compared to BRZE's -17.8%. On growth, BRZE holds the edge at +27.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $458M | $738M | $3.3B | $1.1B | $64.1B |
| EBITDAEarnings before interest/tax | -$31M | -$131M | $166M | $288M | $26.5B |
| Net IncomeAfter-tax profit | -$43M | -$131M | $100M | $217M | $16.2B |
| Free Cash FlowCash after capex | $39M | $61M | $712M | $380M | -$24.7B |
| Gross MarginGross profit ÷ Revenue | +77.6% | +67.1% | +83.7% | +55.6% | +66.4% |
| Operating MarginEBIT ÷ Revenue | -9.5% | -19.6% | +1.9% | +25.6% | +30.8% |
| Net MarginNet income ÷ Revenue | -9.5% | -17.8% | +3.0% | +19.7% | +25.3% |
| FCF MarginFCF ÷ Revenue | +8.6% | +8.2% | +21.6% | +34.5% | -38.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +12.9% | +27.9% | +23.4% | +7.4% | +21.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +28.0% | -70.6% | +2.5% | -3.5% | +24.5% |
Valuation Metrics
SPT leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 39.9x trailing earnings, MANH trades at a 86% valuation discount to HUBS's 284.1x P/E. Adjusting for growth (PEG ratio), MANH offers better value at 1.86x vs ORCL's 6.31x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $409M | $2.3B | $12.6B | $8.5B | $559.3B |
| Enterprise ValueMkt cap + debt − cash | $380M | $2.3B | $12.2B | $8.3B | $652.6B |
| Trailing P/EPrice ÷ TTM EPS | -9.19x | -18.52x | 284.08x | 39.88x | 44.82x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.44x | 35.72x | 19.61x | 26.79x | 25.99x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 1.86x | 6.31x |
| EV / EBITDAEnterprise value multiple | — | — | 69.24x | 28.67x | 27.36x |
| Price / SalesMarket cap ÷ Revenue | 0.89x | 3.13x | 4.02x | 7.86x | 9.74x |
| Price / BookPrice ÷ Book value/share | 1.96x | 3.91x | 6.29x | 27.85x | 26.59x |
| Price / FCFMarket cap ÷ FCF | 10.39x | 37.34x | 17.77x | 22.74x | — |
Profitability & Efficiency
MANH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MANH delivers a 78.2% return on equity — every $100 of shareholder capital generates $78 in annual profit, vs $-23 for SPT. BRZE carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to ORCL's 4.96x. On the Piotroski fundamental quality scale (0–9), HUBS scores 6/9 vs BRZE's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -22.9% | -22.8% | +5.0% | +78.2% | +56.3% |
| ROA (TTM)Return on assets | -9.4% | -12.9% | +2.7% | +28.0% | +8.1% |
| ROICReturn on invested capital | -21.8% | -20.5% | +0.4% | +2.4% | +12.8% |
| ROCEReturn on capital employed | -18.3% | -23.4% | +0.5% | +76.3% | +14.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.33x | 0.13x | 0.23x | 0.36x | 4.96x |
| Net DebtTotal debt minus cash | -$28M | -$42M | -$397M | -$216M | $93.3B |
| Cash & Equiv.Liquid assets | $95M | $124M | $882M | $329M | $10.8B |
| Total DebtShort + long-term debt | $67M | $83M | $485M | $112M | $104.1B |
| Interest CoverageEBIT ÷ Interest expense | -16.09x | — | 4753.07x | — | 5.44x |
Total Returns (Dividends Reinvested)
ORCL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ORCL five years ago would be worth $25,183 today (with dividends reinvested), compared to $1,066 for SPT. Over the past 12 months, ORCL leads with a +31.6% total return vs SPT's -67.1%. The 3-year compound annual growth rate (CAGR) favors ORCL at 27.3% vs SPT's -44.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -34.3% | -30.6% | -36.1% | -14.2% | -0.1% |
| 1-Year ReturnPast 12 months | -67.1% | -30.7% | -62.0% | -21.9% | +31.6% |
| 3-Year ReturnCumulative with dividends | -83.1% | -20.7% | -45.1% | -15.3% | +106.5% |
| 5-Year ReturnCumulative with dividends | -89.3% | -75.8% | -52.1% | +8.1% | +151.8% |
| 10-Year ReturnCumulative with dividends | -59.0% | -75.8% | +469.1% | +145.1% | +425.1% |
| CAGR (3Y)Annualised 3-year return | -44.8% | -7.4% | -18.1% | -5.4% | +27.3% |
Risk & Volatility
Evenly matched — BRZE and MANH each lead in 1 of 2 comparable metrics.
Risk & Volatility
MANH is the less volatile stock with a 1.10 beta — it tends to amplify market swings less than ORCL's 1.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BRZE currently trades 60.0% from its 52-week high vs SPT's 26.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.27x | 1.27x | 1.18x | 1.10x | 1.59x |
| 52-Week HighHighest price in past year | $25.48 | $37.67 | $682.57 | $247.22 | $345.72 |
| 52-Week LowLowest price in past year | $4.92 | $15.26 | $187.45 | $119.06 | $134.57 |
| % of 52W HighCurrent price vs 52-week peak | +26.7% | +60.0% | +35.8% | +58.1% | +56.3% |
| RSI (14)Momentum oscillator 0–100 | 55.9 | 47.6 | 51.1 | 50.6 | 68.5 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 3.0M | 1.5M | 678K | 26.3M |
Analyst Outlook
ORCL leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: SPT as "Buy", BRZE as "Buy", HUBS as "Buy", MANH as "Buy", ORCL as "Buy". Consensus price targets imply 744.1% upside for SPT (target: $57) vs 32.2% for ORCL (target: $257). ORCL is the only dividend payer here at 0.85% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $57.40 | $42.44 | $360.89 | $197.25 | $257.19 |
| # AnalystsCovering analysts | 16 | 25 | 47 | 15 | 86 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.9% |
| Dividend StreakConsecutive years of raises | — | — | — | 2 | 18 |
| Dividend / ShareAnnual DPS | — | — | — | — | $1.65 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +4.0% | +3.7% | +0.3% |
ORCL leads in 2 of 6 categories (Total Returns, Analyst Outlook). SPT leads in 1 (Valuation Metrics). 2 tied.
SPT vs BRZE vs HUBS vs MANH vs ORCL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SPT or BRZE or HUBS or MANH or ORCL a better buy right now?
For growth investors, Braze, Inc.
(BRZE) is the stronger pick with 24. 4% revenue growth year-over-year, versus 3. 7% for Manhattan Associates, Inc. (MANH). Manhattan Associates, Inc. (MANH) offers the better valuation at 39. 9x trailing P/E (26. 8x forward), making it the more compelling value choice. Analysts rate Sprout Social, Inc. (SPT) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SPT or BRZE or HUBS or MANH or ORCL?
On trailing P/E, Manhattan Associates, Inc.
(MANH) is the cheapest at 39. 9x versus HubSpot, Inc. at 284. 1x. On forward P/E, Sprout Social, Inc. is actually cheaper at 7. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Manhattan Associates, Inc. wins at 1. 25x versus Oracle Corporation's 3. 66x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — SPT or BRZE or HUBS or MANH or ORCL?
Over the past 5 years, Oracle Corporation (ORCL) delivered a total return of +151.
8%, compared to -89. 3% for Sprout Social, Inc. (SPT). Over 10 years, the gap is even starker: HUBS returned +469. 1% versus BRZE's -75. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SPT or BRZE or HUBS or MANH or ORCL?
By beta (market sensitivity over 5 years), Manhattan Associates, Inc.
(MANH) is the lower-risk stock at 1. 10β versus Oracle Corporation's 1. 59β — meaning ORCL is approximately 44% more volatile than MANH relative to the S&P 500. On balance sheet safety, Braze, Inc. (BRZE) carries a lower debt/equity ratio of 13% versus 5% for Oracle Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — SPT or BRZE or HUBS or MANH or ORCL?
By revenue growth (latest reported year), Braze, Inc.
(BRZE) is pulling ahead at 24. 4% versus 3. 7% for Manhattan Associates, Inc. (MANH). On earnings-per-share growth, the picture is similar: HubSpot, Inc. grew EPS 863. 0% year-over-year, compared to -19. 6% for Braze, Inc.. Over a 3-year CAGR, BRZE leads at 27. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SPT or BRZE or HUBS or MANH or ORCL?
Oracle Corporation (ORCL) is the more profitable company, earning 21.
7% net margin versus -17. 8% for Braze, Inc. — meaning it keeps 21. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ORCL leads at 30. 8% versus -19. 6% for BRZE. At the gross margin level — before operating expenses — HUBS leads at 83. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SPT or BRZE or HUBS or MANH or ORCL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Manhattan Associates, Inc. (MANH) is the more undervalued stock at a PEG of 1. 25x versus Oracle Corporation's 3. 66x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Sprout Social, Inc. (SPT) trades at 7. 4x forward P/E versus 35. 7x for Braze, Inc. — 28. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SPT: 744. 1% to $57. 40.
08Which pays a better dividend — SPT or BRZE or HUBS or MANH or ORCL?
In this comparison, ORCL (0.
9% yield) pays a dividend. SPT, BRZE, HUBS, MANH do not pay a meaningful dividend and should not be held primarily for income.
09Is SPT or BRZE or HUBS or MANH or ORCL better for a retirement portfolio?
For long-horizon retirement investors, Oracle Corporation (ORCL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0.
9% yield, +425. 1% 10Y return). Both have compounded well over 10 years (ORCL: +425. 1%, BRZE: -75. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SPT and BRZE and HUBS and MANH and ORCL?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SPT is a small-cap quality compounder stock; BRZE is a small-cap high-growth stock; HUBS is a mid-cap high-growth stock; MANH is a small-cap quality compounder stock; ORCL is a large-cap quality compounder stock. ORCL pays a dividend while SPT, BRZE, HUBS, MANH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.